20.91
price up icon4.81%   0.96
after-market アフターアワーズ: 20.91
loading
前日終値:
$19.95
開ける:
$19.82
24時間の取引高:
93,173
Relative Volume:
1.16
時価総額:
$873.57M
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+1.55%
1か月 パフォーマンス:
+11.16%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
Value
$19.39
$21.18
1週間の範囲:
Value
$19.39
$22.18
52週間の値動き範囲:
Value
$16.17
$26.25

Zenas Biopharma Inc Stock (ZBIO) Company Profile

Name
名前
Zenas Biopharma Inc
Name
セクター
Healthcare (1182)
Name
電話
-
Name
住所
-
Name
職員
0
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
ZBIO's Discussions on Twitter

Zenas Biopharma Inc (ZBIO) 最新ニュース

pulisher
Oct 22, 2024

Zenas Bio: Recent IPO With Late-Stage Candidate (NASDAQ:ZBIO) - Seeking Alpha

Oct 22, 2024
pulisher
Oct 08, 2024

Zenas started at buy by four banks on lead drug potential (NASDAQ:ZBIO) - Seeking Alpha

Oct 08, 2024
pulisher
Oct 08, 2024

Zenas stock backed by Guggenheim on strong outlook for lead drug obexelimab - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Morgan Stanley bullish on Zenas Biopharma stock as obexelimab trials gain momentum - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Citi sees upside in Zenas Biopharma stock as obexelimab progresses in key trials - Investing.com Canada

Oct 08, 2024
pulisher
Oct 08, 2024

Jefferies bullish on Zenas stock as obexelimab advances in autoimmune trials - Investing.com Canada

Oct 08, 2024
pulisher
Oct 04, 2024

Biopharma financings surge to $86.2B in 2024, with $8.7B in September - BioWorld Online

Oct 04, 2024
pulisher
Oct 01, 2024

Halda appoints new chief executive - The Pharma Letter

Oct 01, 2024
pulisher
Sep 27, 2024

IgG4-related Disease Market to Show Remarkable Growth Trends - openPR

Sep 27, 2024
pulisher
Sep 22, 2024

Last Week's 3 Biotech IPOs Prompt Huge Insider Buying - 24/7 Wall St.

Sep 22, 2024
pulisher
Sep 21, 2024

Biotech IPO Shares Climb in Debuts After Deals Upsized - MSN

Sep 21, 2024
pulisher
Sep 21, 2024

Zenas BioPharma CEO acquires $360k worth of company shares - Investing.com India

Sep 21, 2024
pulisher
Sep 20, 2024

Zenas BioPharma CEO acquires $360k worth of company shares By Investing.com - Investing.com South Africa

Sep 20, 2024
pulisher
Sep 20, 2024

Zenas BioPharma’s $225 Million IPO - Global Legal Chronicle

Sep 20, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering - The Korea Bizwire

Sep 19, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase ... - The Bakersfield Californian

Sep 19, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of - GlobeNewswire

Sep 19, 2024
pulisher
Sep 19, 2024

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in - EIN News

Sep 19, 2024
pulisher
Sep 19, 2024

Upstream Bio goes public amid spate of IPOs - The Pharma Letter

Sep 19, 2024
pulisher
Sep 18, 2024

Zenas BioPharma sees $15 million in stock purchases by Zebra Aggregator - Investing.com South Africa

Sep 18, 2024
pulisher
Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock By Investing.com - Investing.com South Africa

Sep 17, 2024
pulisher
Sep 17, 2024

Zenas BioPharma director acquires $999k in company stock - Investing.com Canada

Sep 17, 2024
pulisher
Sep 17, 2024

IPOs, GLP-1 vs. PD-1, and AI in biotech: a BioCentury podcast - BioCentury

Sep 17, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director buys $7.48m in company stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director buys $7.48m in company stock - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director Jason Raleigh acquires $15 million in company stock By Investing.com - Investing.com South Africa

Sep 16, 2024
pulisher
Sep 16, 2024

Zenas BioPharma director Jason Raleigh acquires $15 million in company stock - Investing.com India

Sep 16, 2024
pulisher
Sep 16, 2024

Fairmount Healthcare Fund II L.P. buys $5.1m of Zenas BioPharma stock - Investing.com India

Sep 16, 2024
pulisher
Sep 16, 2024

SR One Capital management buys $38m of Zenas BioPharma stock - Investing.com Australia

Sep 16, 2024
pulisher
Sep 16, 2024

MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last? - Scrip

Sep 16, 2024
pulisher
Sep 14, 2024

Biotech IPO Shares Climb in Trading Debuts After Deals Upsized - MSN

Sep 14, 2024
pulisher
Sep 14, 2024

Biotech IPO Shares Climb in Trading Debuts After Deals Upsized | Stock Market News - Mint

Sep 14, 2024
pulisher
Sep 13, 2024

Biotech IPOs Surge on Debut: Upsized Deals Boost Shares for Drug Developers Tackling Autoimmune Diseases - Share Price India News

Sep 13, 2024
pulisher
Sep 13, 2024

Trio of first-day pops may bode well for biotech IPO window - BioCentury

Sep 13, 2024
pulisher
Sep 13, 2024

Biotech Startups Make Pre-Election Sprint to the Public Markets - The Wall Street Journal

Sep 13, 2024
pulisher
Sep 13, 2024

2 Life Sciences Cos. Start Trading After Raising $540M Total - Law360

Sep 13, 2024
pulisher
Sep 13, 2024

Biotech trio revives the IPO market - Axios

Sep 13, 2024
pulisher
Sep 13, 2024

3 Biotech IPOs, $703M Raised for Clinical Trials in Cancer, Immunology & Endocrine Disorders - MedCity News

Sep 13, 2024
pulisher
Sep 13, 2024

Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals

Sep 13, 2024

Zenas Biopharma Inc (ZBIO) 財務データ

Zenas Biopharma Inc (ZBIO) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Zenas Biopharma Inc (ZBIO) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
MOULDER LEON O JR
Chief Executive Officer
Sep 20 '24
Buy
18.45
5,000
92,270
1,672,039
MOULDER LEON O JR
Chief Executive Officer
Sep 19 '24
Buy
17.89
5,000
89,450
1,667,039
Enavate Sciences GP, LLC
10% Owner
Sep 16 '24
Buy
17.00
882,353
15,000,001
3,761,359
Lu Hongbo
Director
Sep 13 '24
Buy
17.00
58,823
999,991
58,823
ENRIGHT PATRICK G
Director
Sep 16 '24
Buy
17.00
440,000
7,480,000
774,530
Nunn Jason Raleigh
Director
Sep 16 '24
Buy
17.00
882,352
14,999,984
1,946,564
Fairmount Funds Management LLC
Director
Sep 16 '24
Buy
17.00
300,000
5,100,000
1,604,891
SR ONE CAPITAL MANAGEMENT, LLC
10% Owner
Sep 16 '24
Buy
17.00
2,235,294
37,999,998
1,946,564
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
大文字化:     |  ボリューム (24 時間):